Changhuei Yang is the Thomas G. Myers Professor of Electrical Engineering, Bioengineering, and Medical Engineering at California Institute of Technology, serving as Executive Officer for Electrical Engineering and Investigator at Heritage Medical Research Institute. He holds a Ph.D. and three master's degrees from MIT, with appointments at Caltech since 2003. Research focuses on: Advanced microscopy techniques including Fourier Ptychography Wavefront shaping for biological tissue imaging Optical phase conjugation for deep-tissue applications Compact medical devices for cerebral monitoring Publications demonstrate leadership in computational imaging, with recent advances in stain-free embryo analysis, portable cerebral blood flow monitors, and high-resolution volumetric imaging techniques using neural representations. Honored as National Academy of Inventors member. Research applications span deep-tissue biochemical imaging, incisionless surgery, and optogenetic activation systems.
Clinical Associate Professor Keith Ong is affiliated with the University of Sydney’s Northern Clinical School, specifically within the Department of Clinical Ophthalmology & Eye Health. His clinical specialty is Ophthalmology, with a focus on corneal endothelial health, glaucoma surgery outcomes, and cataract surgical techniques. His research addresses critical areas such as postoperative ocular toxicity, intraocular lens calculations, and infection control in eye surgeries. Dr. Ong’s publications (2011–2023) consistently explore topics like corneal endothelial changes post-trabeculectomy, refractive error management post-cataract surgery, and antibiotic prophylaxis strategies. Recent work emphasizes optimizing surgical techniques to reduce complications, such as BAK-induced corneal toxicity and IOL power calculation accuracy in LASIK patients. His work demonstrates a focus on improving surgical safety and precision, with studies evaluating alternative antibiotic delivery methods and laser therapy impacts. No awards or grants are explicitly noted in the provided text, but his contributions to clinical practice and surgical protocols are evident through his publication record.
Dr. John Males is a Clinical Senior Lecturer at the University of Sydney and Director of Ophthalmology Training at Sydney Eye Hospital. His clinical and research expertise focuses on corneal surgery, cataract surgery, and laser vision correction. He pioneered Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) in Australia and is conducting clinical trials on Collagen Cross-Linking for keratoconus. His research spans corneal transplantation techniques, refractive error management, and ocular surface regeneration. Dr. Males holds roles as a consultant at major hospitals and serves as an examiner for the Royal Australian & New Zealand College of Ophthalmologists. Research interests include corneal biomechanics, surgical innovation for keratoconus, and outcomes analysis of cross-linking therapies. He leads studies on corneal densitometry, dry eye correlations, and long-term efficacy of surgical interventions. His work bridges clinical practice with translational research in regenerative medicine and ocular surface engineering. Publications span over 20 years, emphasizing corneal transplantation advancements, keratoconus management, and surgical complication resolution. His contributions to global consensus guidelines for endothelial keratoplasty highlight leadership in standardizing surgical practices.
Professor Gerard Sutton is an Honorary Professor in the Faculty of Medicine and Health at the University of Sydney, affiliated with the Save Sight Institute and Vision Eye Institute. He specializes in corneal and refractive surgery, combining clinical practice with research in keratoconus, corneal bioengineering, and global eye care. His work includes developing the Australian Corneal Bioengineering Centre and pioneering innovations like the Corneal Biopen for treating corneal defects. Research interests span clinical and laboratory-based studies, focusing on corneal transplantation, bioengineered treatments, and refractive surgery outcomes. Current projects include corneal bioengineering, keratoconus pathogenesis, and SMILE surgery clinical outcomes. He holds memberships in prominent ophthalmology societies like RANZCO and APPO. Awards: 2019 RANZCO John C. Parr Medal Lecture Award 2017 Sydney Research Centre ‘Big Idea’ Innovation Award 2015 XOVA Excellence in International Ophthalmology 2014 Asia Pacific Academy of Ophthalmology Achievement Award Grants & Funding: AU$35M BIENCO consortium (2023) for corneal blindness therapies AU$1.1M Corneal Biopen commercialization (2018) NHMRC Ideas Grant for bioengineered corneal layers (2019) His research group collaborates internationally, with projects addressing corneal transplantation equity, bioink development, and regenerative solutions for ocular surface diseases. Clinical affiliations include Sydney Eye Hospital and the Lions NSW Eye Bank.
Anja Liekfeld serves as Adjunct Professor of Ophthalmic Optics/Optical Device Technology at Brandenburg University of Technology since 2018 while concurrently holding the position of Chief Physician at Klinikum Ernst von Bergmann's Department of Ophthalmology in Potsdam since 2009. Her dual roles bridge academic research in optical engineering with clinical ophthalmology practice, focusing on technological advancements for eye care delivery. Her educational foundation includes medical studies at Essen and Berlin Universities (1986-1992), state examination (1992), ophthalmology residency at Charité (1994-1997), specialist certification (1997), doctoral degree magna cum laude (1997), and habilitation on capsular bag models for cataract research (2007). Liekfeld's research centers on optical properties of intraocular lenses, clinical applications of medical devices in ophthalmology, refractive surgery techniques (laser and IOLs), cataract surgery technologies, glaucoma diagnostics/therapy, and gerontological ophthalmology. Her work emphasizes translating engineering principles into clinical solutions for complex vision correction challenges. Over 25 years of publications reveal evolving expertise from molecular glaucoma research to advanced IOL development. Recent work focuses on multifocal/toric lenses, dysphotopsia analysis, and visual outcomes measurement, demonstrating consistent innovation at the optics-clinical interface with practical applications for patient care. Her accolades include: DOG/SFO Travel Grant (2000) DGII Best Presentation Award (2008) DOC Gold Medal (2011) Focus Magazine Top Doctor (2013-2021) Stern Magazine Top Doctor (2022) As an educator, she trains surgical assistants, diet technicians, and operating room staff while teaching ophthalmology to visually impaired pedagogy students at Humboldt University. She conducts international wet labs for surgeons and optometrists, serves on editorial boards for Concept and Karger Kompass Ophthalmologie, and reviews for major ophthalmology journals. Active in professional societies including DGII, ESCRS, DOG, BBAG, and BDOC, she chairs Brandenburg's Ophthalmology Examination Board since 2021 and serves on the board of Die Augenchirurginnen e.V. Her research utilizes human capsular bag models for cataract studies and maintains focus on improving optical device performance in clinical settings.
Stacy L. Pineles, MD, MS is a Professor of Ophthalmology and Residency Program Director at the Stein Eye Institute, David Geffen School of Medicine at the University of California, Los Angeles (UCLA). She also serves as Chair-Elect of the Pediatric Eye Disease Investigator Group (PEDIG), a collaborative network funded by the National Eye Institute dedicated to facilitating multicenter clinical research in strabismus, amblyopia, and other eye disorders affecting children. Dr. Pineles is affiliated with Ronald Reagan UCLA Medical Center and UCLA Santa Monica Medical Center as hospital affiliations. Dr. Pineles completed her medical training at the University of Pennsylvania in 2004, followed by ophthalmology residency at UCLA (2005-2008), pediatric ophthalmology fellowship at UCLA (2009), neuro-ophthalmology fellowship at the University of Pennsylvania (2010), and a Master's degree in Clinical Investigation at UCLA (2013). She joined the UCLA faculty in 2010 and became Residency Program Director in 2017. Her primary research interests focus on pediatric neuro-ophthalmology and strabismus, with specific emphasis on binocular vision in children and adults with eye misalignment, systemic effects of pediatric eye disease, and clinical trials in pediatric ophthalmology. Dr. Pineles serves as principal investigator of an NIH-sponsored multicenter study of pediatric optic neuritis. She runs an NIH-sponsored research program evaluating binocular vision in children and adults with eye misalignment. Analysis of Dr. Pineles' publications reveals consistent research activity in pediatric ophthalmology, neuro-ophthalmology, and strabismus, with particular focus on binocular vision, optic neuritis, and surgical outcomes. Her work spans clinical trials, diagnostic accuracy studies, and innovative surgical techniques, demonstrating expertise in both clinical care and research methodology. Super Doctors® Southern California, 2022-2025 AAPOS Young Investigator Award, 2019 University of California OptumLabs Research Credit Award, 2018 Appointment of Jerome and Joan Snyder Chair in Ophthalmology, 2017 American Academy of Ophthalmology Achievement Award, 2016 AAPOS Honors Award, 2016 Dr. Pineles serves on numerous professional committees within the American Academy of Ophthalmology, American Association of Pediatric Ophthalmology and Strabismus, and the North American Neuro-Ophthalmology Society. She travels regularly nationally and internationally to speak on topics related to her research in pediatric neuro-ophthalmology. As Residency Program Director since 2017, she oversees ophthalmology training at UCLA. She is author of more than 100 peer-reviewed publications and 10 book chapters. Dr. Pineles leads the Pediatric Ophthalmology division at the Stein Eye Institute, which is part of one of the world's leading centers of vision science. Her research program includes multicenter clinical trials and NIH-sponsored studies evaluating binocular vision and pediatric optic neuritis. She actively collaborates with the Pediatric Eye Disease Investigator Group (PEDIG), a network of over 100 participating sites with more than 300 pediatric ophthalmologists and optometrists across the United States, Canada, and the United Kingdom.
Professor Emanuele (Manuel) Trucco is the NRP Chair of Computational Vision in the Department of Computing, School of Science and Engineering, at the University of Dundee. He holds additional roles as an Honorary Clinical Researcher at NHS Tayside and formerly served as an Adjunct Professor at the Chinese Academy of Sciences from 2018 to 2021. He earned his MSc and PhD in Electronic Engineering from the University of Genoa, Italy, in 1984 and 1990, respectively. His research focuses on medical image and data analysis, particularly in retinal imaging, using machine and deep learning techniques. He is co-director of VAMPIRE, a major international initiative in retinal image analysis, which supports biomarker studies in cardiovascular disease, diabetes, dementia, and neurodegenerative disorders. His recent work includes AI-driven tools for predicting dementia from brain scans and cardiovascular risk from retinal images. The latest publications reflect strong trends in applying deep learning to retinal and brain imaging for early disease detection, with themes centered on AI in healthcare, precision medicine, and non-invasive diagnostics. FRSA (Fellow of the Royal Society of Arts) FIAPR (Fellow of the International Association for Pattern Recognition) Professor Trucco has led and co-led significant research projects funded by EPSRC, NIHR, and EU programs. He has supervised PhD students through industry-sponsored studentships (e.g., OPTOS, NIDEK, Toshiba) and collaborated with institutions such as the Universities of Edinburgh and Liverpool. His research is supported by extensive industrial partnerships including Canon Medical, Epipole plc, and NIDEK. He is a key member of the UK Biobank Eye and Vision Consortium and co-director of the VAMPIRE initiative, a collaborative effort between the Universities of Dundee and Edinburgh focused on retinal image analysis. His work also involves participation in major research networks such as the Academic Health Science Partnership in Tayside.
Allison E. Rizzuti, MD, is a board-certified Clinical Associate Professor of Ophthalmology at SUNY Downstate Health Sciences University. She serves as Co-Director of the Cornea Service and specializes in comprehensive ophthalmology, corneal & external disease, and cataract surgery. Dr. Rizzuti actively trains ophthalmology residents at Kings County Hospital Center and South Brooklyn Health, focusing on clinical practice and surgical expertise. Undergraduate: Barnard College Medical School: SUNY Downstate Health Sciences University Internship: Lenox Hill Hospital (Internal Medicine) Residency: SUNY Downstate Health Sciences University (Ophthalmology) Fellowship: SUNY Downstate Health Sciences University (Cornea & Refractive Surgery) Dr. Rizzuti's research emphasizes the medical and surgical management of corneal and external diseases, alongside advancements in cataract surgical techniques. Her work spans diverse topics such as intravitreal injection methods, ocular trauma management, autoimmune corneal disorders, and chemotherapy's impact on retinoblastoma patients. She has contributed to multiple peer-reviewed publications and textbook chapters. Dr. Rizzuti's recent publications highlight clinical trials, surgical innovations, and rare ocular pathologies. Key trends include optimizing intravitreal injection techniques for patient comfort, improving outcomes in anterior segment trauma, and exploring amniotic membrane applications in corneal repair. Her work bridges clinical practice with academic research. New York Super Doctors® Rising Star Member with Thesis, Cornea Society Fellow, American Academy of Ophthalmology Executive Committee, American Society of Ophthalmic Trauma Dr. Rizzuti is a key clinical educator for ophthalmology residents and practices at NYC Health + Hospitals / South Brooklyn Health. She has held leadership roles in professional societies and maintains an active publication record in corneal disease and surgical advancements.
Prof. Dr. Orkun Müftüoğlu is a Professor at Koç University Hospital (2015–present) and previously at Medipol University School of Medicine (2013–2015). He completed subspecialty training in Cataract & Refractive Surgery (Baylor College of Medicine, 2003), Vitreoretinal Surgery (Duke University, 2006), and Advanced Refractive Surgery (Instituto Alicante, 2007), with over 20,000 surgical cases to his credit. Education: Cataract, Cornea & Artificial Cornea, Refractive Surgery: University of Texas Southwestern Medical Center (2007–2009) Vitreoretinal Surgery: Duke University (2006) Cataract & Refractive Laser Surgery: Baylor College of Medicine (2003) Ophthalmology Residency: Ankara University School of Medicine (1999–2003) Medical Education: Ankara University (1993–1999), Baylor College of Medicine (1999) Clinical Expertise: Specializes in complex cataract surgery, refractive procedures (myopia/hypermetropia/astigmatism), corneal disease management (including keratoconus), glaucoma, artificial cornea, and vitreoretinal surgery. Holds American Medical License (USMLE-ECFMG) and has performed one-on-one surgeries in the U.S. Scientific Recognition: Awarded first prizes by the American Academy of Ophthalmology and ESCRS. Active member of Turkish Ophthalmological Association, American Academy of Ophthalmology, and ESCRS committees for education and young ophthalmologists.
Professor Jonathan Erichsen serves as Professor of Visual Neuroscience and Deputy Head of School within the School of Optometry and Vision Sciences at Cardiff University. With a distinguished career spanning several decades, he has established himself as a leading researcher in visual neuroscience and eye movement disorders. Professor Erichsen's research has evolved from early work on central near response pathways in the brain, including vergence and the pupillary light reflex, to a broader focus on eye movement disorders. His primary research interests include the control of visuomotor behavior, eye movement abnormalities in neurodegenerative conditions, and visual function assessment in individuals with nystagmus. He has pioneered innovative methodologies including stereotaxic surgery, immunohistochemistry, neural pathway tracing, and microstimulation in his investigations. His recent publications demonstrate a clear trend toward clinical applications of eye movement research, particularly in developing better assessment tools for visual function in nystagmus patients. The research spans from fundamental neuroanatomy to practical clinical tools, with significant contributions to understanding infantile nystagmus, Huntington's disease-related eye movement abnormalities, and visual function in children. His work increasingly integrates advanced eye tracking technologies with clinical applications. Professor Erichsen founded the Cardiff Research Unit for Nystagmus (RUN) approximately twenty years ago, establishing a large cohort of volunteers with infantile nystagmus to study how environmental factors like stress affect visual performance. More recently, he established the Eye Movement Experimental Research Group (EMERG) to expand research into eye movement abnormalities associated with neurodegenerative conditions including Huntington's disease, schizophrenia risk, and dystonia. His research has demonstrated that traditional measures of visual performance, such as visual acuity, are not significantly affected by changes in eye movements of individuals with nystagmus, suggesting the need for developing better outcome measures in clinical practice. Professor Erichsen remains actively involved in postgraduate supervision and continues to produce high-impact research in visual neuroscience.
Dr. Gregory Hill is an Assistant Professor at the College of Optometry, Nova Southeastern University. He holds a Doctor of Optometry (O.D.) from Indiana University School of Optometry (1995). His career spans diverse practice modalities including private practice, corporate retail care, refractive surgery management, and hospital-based ophthalmology co-management. He has contributed to ecological research via a National Science Foundation study on prairie ecosystems and co-authored related journal articles. Dr. Hill is actively involved in professional organizations, including leadership roles in the South Dakota chapter of Volunteer Optometric Services to Humanity (VOSH), and has led mission trips to Mexico, Jamaica, and Native American reservations. Education: Indiana University School of Optometry (O.D., 1995), undergraduate studies with NSF-funded ecosystem research. His research interests bridge clinical optometry and ecological science, emphasizing interdisciplinary collaboration. Dr. Hill advocates for continuous learning and professional integrity, reflecting in his teaching roles in undergraduate biology and optometric lab sections. He is a certified refractive surgery specialist and has received multiple academic honors, including Dean’s List recognition throughout his undergraduate career. Awards/Honors: Advanced Clinical Certification (TLC Vision), membership in two honor societies, VOSH leadership. He emphasizes community engagement through knowledge-sharing, exemplified by media appearances on eye care topics and continuing education lectures for healthcare professionals.
Tos T.J.M. Berendschot is a University Researcher in Biomedical Engineering at Eindhoven University of Technology , specializing in Medical Image Analysis . His work spans interdisciplinary domains linking diabetes, neurodegeneration, and ophthalmology. Email: t.t.j.m.berendschot@tue.nl Research Interests focus on diabetic complications, retinal neurodegeneration, and AI-driven medical imaging. Key areas include: Maturity Onset Diabetes of the Young (MODY) Microvascular dysfunction Advanced Glycation End-Products (AGEs) Retinal vascular tree analysis Keratoconus detection via AI Optical Coherence Tomography (OCT) Selected Publications highlight AI applications in ophthalmology, diabetic neurodegeneration, and vascular connectivity studies. Collaborations include Maastricht University Medical Center and international conferences in computer vision. Media Contributions feature expert commentary on cataract surgery, keratoconus, Alzheimer's disease biomarkers, and intraocular lens calculations.
Chris Hammond serves as the Frost Professor of Ophthalmology at King's College London's Faculty of Life Sciences & Medicine, School of Life Course & Population Sciences, and has been Head of Section for Ophthalmology Research since 2011. He is also a Consultant Ophthalmologist specializing in pediatric ophthalmology and squint surgery at St Thomas' Hospital, demonstrating a strong clinical-academic integration in his career. Professor Hammond's research primarily focuses on the genetic basis of common eye diseases including glaucoma, myopia, dry eye disease, and age-related cataract. His work integrates twin research methodologies with advanced genomic approaches to understand the heritability and genetic factors underlying these conditions. He has established himself as one of the leading scientists in ophthalmic genetics through groundbreaking research showing that many age-related eye diseases have significant genetic components. His publication record reveals a strong emphasis on large-scale genetic studies, particularly utilizing the UK Biobank resource. His research spans from basic genetic discovery to clinical applications, with particular focus on dry eye disease mechanisms, myopia development pathways, and glaucoma genetics. The work consistently involves international collaborations across multiple institutions. Professor Hammond actively leads research teams focused on ophthalmic genetics, with his laboratory work centering on understanding the genetic architecture of eye diseases through twin studies and genome-wide association studies. His research has important implications for developing better prevention strategies and personalized treatment approaches for common eye conditions.
Sergio Barbero is an Associate Researcher at the Visual Optics laboratory of the Instituto de Óptica (CSIC), Spain, under the supervision of Prof. Susana Marcos. He holds a BSc in Physics from the University of Zaragoza (1999) and a PhD in Visual Sciences from the University of Valladolid (2004), which earned him the Doctoral Thesis Extraordinary Award (2005). His research focuses on optical aberrations, intraocular lens design, wavefront measurement techniques, and gradient-index modeling of ocular structures. Barbero has collaborated with international groups at Indiana University (USA), University of Houston (USA), and Australian institutions. His work includes pioneering studies on crystalline lens tomography, corneal ablation algorithms, and novel wavefront sensing methods. He has authored 16 peer-reviewed publications and contributed to a US patent on wavefront reconstruction techniques. His research spans three core areas: (1) intraocular lens design using analytical tools, (2) gradient-index modeling of the human eye, and (3) in vivo measurement of crystalline lens aberrations. He has secured grants from the Spanish government (I3P-CSIC), NIH (USA), and Fulbright fellowships. Barbero has presented 33 scientific talks/posters, including invited lectures, and maintains an h-index of 9. His work bridges fundamental optics with clinical applications in ophthalmology.
Dr. Meng-Hua Wu serves as an Associate Clinical Professor at the University of California, Berkeley, specializing in ocular disease management as a Doctor of Optometry (OD) and Fellow of the American Academy of Optometry (FAAO). Her academic credentials include: Doctor of Optometry (OD), University of California, Berkeley, 2017 Residency in Ocular Disease, University of California, Berkeley, 2018 Dr. Wu's clinical expertise centers on comprehensive ocular disease treatment with specialized proficiency in refractive surgery (LASIK/PRK), cataract surgery, and glaucoma interventions. She pioneers telemedicine applications for diabetic retinopathy screening in underserved rural communities, emphasizing patient education to prevent vision impairment affecting daily functionality. Her practice philosophy prioritizes translating complex ocular health concepts into actionable patient knowledge. Professional recognition: Fellow of the American Academy of Optometry (FAAO)
